Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 237,996 | 162,833 | 131,485 | 50,061 | 11,917 |
| Depreciation Amortization | 115,837 | 15,518 | 7,220 | 36,145 | 37,907 |
| Income taxes - deferred | 46,657 | 7,026 | 1,889 | -10,379 | -9,430 |
| Accounts receivable | 90,072 | 49,686 | -138,929 | -142,777 | -18,368 |
| Other Working Capital | 111,721 | 79,398 | -78,918 | -97,257 | -6,064 |
| Other Operating Activity | -342,398 | -86,345 | 114,865 | 156,050 | -18,329 |
| Operating Cash Flow | $259,885 | $228,116 | $37,612 | $-8,157 | $-2,367 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -133,606 | -91,899 | 12,048 | -7,370 | -1,815 |
| PPE Investments | -10,541 | -7,690 | -3,116 | -13,667 | -8,405 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -750 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -750 | 0 |
| Investing Cash Flow | $-144,147 | $-99,589 | $8,932 | $-21,787 | $-10,220 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -12,887 | -12,887 |
| Common Stock Issued | 13,927 | 12,818 | 4,695 | 5,113 | 3,776 |
| Other Financing Activity | 4,337 | 4,329 | 738 | 213 | 0 |
| Financing Cash Flow | $18,264 | $17,147 | $5,433 | $-7,561 | $-9,111 |
| Beginning Cash Position | 31,770 | 31,770 | 31,770 | 69,275 | 69,275 |
| End Cash Position | 165,772 | 177,444 | 83,747 | 31,770 | 47,577 |
| Net Cash Flow | $134,002 | $145,674 | $51,977 | $-37,505 | $-21,698 |
| Free Cash Flow | |||||
| Operating Cash Flow | 259,885 | 228,116 | 37,612 | -8,157 | -2,367 |
| Capital Expenditure | -10,541 | -7,690 | -3,116 | -13,667 | -8,405 |
| Free Cash Flow | 249,344 | 220,426 | 34,496 | -21,824 | -10,772 |